Cost reduction: Rising costs and inflation lead to increased medical costs. Making health accessible and accessible to all is a major challenge. The government has started efforts in this direction with the Ayushman Bharat initiative. However, because inflation is a dynamic metric, limiting medical costs will remain an ongoing challenge.
Foreign regulations: Indian pharmaceutical companies generate high export earnings. Foreign regulations and compliance standards are challenging that Indian pharmaceutical companies have to face. Trade restrictions, export and import regulations, tariffs, and taxes are some of the challenges Indian pharmaceutical companies face in the international market.
New disease: The new coronavirus rocked the world from the start in 2020. The world is still waiting for a vaccine. This is just one example of the challenges this industry faces. The pharmaceutical sector needs to continuously update its infrastructure and research and development to combat new diseases and develop drugs for existing diseases.
Medical infrastructure: This includes hospitals, medical specialists and educational institutions, pharmaceuticals, pharmacies, small medical centers, laboratories, vaccines, process machinery, production infrastructure for pharmaceuticals, and everything else that supports the industry on-site. Maintaining the quality of infrastructure and extending it to all urban and rural areas is also a challenge for the industry.
Foreign direct investment (FDI) in the Indian pharma sector: In the pharmaceutical sector, 100% FDI is allowed, provided that up to 100% FDI is automatically allowed in green pharmaceutical projects; and FDI of up to 74% in brownfield pharmaceutical projects allowed on the automated route, then the government route.
Medical spending in India is expected to increase in the coming years. This places a great responsibility on the government and stakeholders in the pharmaceutical sector in maintaining public health in general. The future of the industry depends on the ability of the medical infrastructure to develop a formidable battle against many illnesses and other tasks for the industry.
